Connection

Michael Madaio to Lupus Nephritis

This is a "connection" page, showing publications Michael Madaio has written about Lupus Nephritis.
Connection Strength

3.617
  1. The relevance of antigen binding to the pathogenicity of lupus autoantibodies. Kidney Int. 2012 Jul; 82(2):125-7.
    View in: PubMed
    Score: 0.376
  2. Biomarkers in lupus nephritis. Rheum Dis Clin North Am. 2010 Feb; 36(1):131-43, ix.
    View in: PubMed
    Score: 0.318
  3. Pathogenic autoantibodies in lupus nephritis. Lupus. 2005; 14(1):19-24.
    View in: PubMed
    Score: 0.224
  4. Recent advances in the pathogenesis of lupus nephritis: autoantibodies and B cells. Semin Nephrol. 2003 Nov; 23(6):564-8.
    View in: PubMed
    Score: 0.206
  5. The role of antibodies and B cells in the pathogenesis of lupus nephritis. Springer Semin Immunopathol. 2003 May; 24(4):363-75.
    View in: PubMed
    Score: 0.199
  6. Intrathymic kidney cells delay the onset of lupus nephritis in MRL-lpr/lpr mice. Int Immunol. 2002 Aug; 14(8):867-71.
    View in: PubMed
    Score: 0.189
  7. The role of autoantibodies in the pathogenesis of lupus nephritis. Semin Nephrol. 1999 Jan; 19(1):48-56.
    View in: PubMed
    Score: 0.148
  8. iRhom2 promotes lupus nephritis through TNF-a and EGFR signaling. J Clin Invest. 2018 04 02; 128(4):1397-1412.
    View in: PubMed
    Score: 0.139
  9. B cells and autoantibodies in the pathogenesis of lupus nephritis. Immunol Res. 1998; 17(1-2):123-32.
    View in: PubMed
    Score: 0.138
  10. Structural features of nephritogenic lupus autoantibodies. Methods. 1997 Jan; 11(1):62-9.
    View in: PubMed
    Score: 0.129
  11. Lupus autoantibodies interact directly with distinct glomerular and vascular cell surface antigens. Kidney Int. 1996 May; 49(5):1214-21.
    View in: PubMed
    Score: 0.123
  12. Emerging concepts regarding B cells and autoantibodies in murine lupus nephritis. B cells have multiple roles; all autoantibodies are not equal. J Am Soc Nephrol. 1996 Mar; 7(3):387-96.
    View in: PubMed
    Score: 0.121
  13. Glomerular autoimmune multicomponents of human lupus nephritis in vivo: a-enolase and annexin AI. J Am Soc Nephrol. 2014 Nov; 25(11):2483-98.
    View in: PubMed
    Score: 0.107
  14. Nephritogenic autoantibodies in systemic lupus erythematosus: immunochemical properties, mechanisms of immune deposition, and genetic origins. Lab Invest. 1993 Nov; 69(5):494-507.
    View in: PubMed
    Score: 0.103
  15. Anti-tumor necrosis factor a treatment of interferon-a-induced murine lupus nephritis reduces the renal macrophage response but does not alter glomerular immune complex formation. Arthritis Rheum. 2012 Oct; 64(10):3399-408.
    View in: PubMed
    Score: 0.096
  16. Anti-DNA antibodies form immune deposits at distinct glomerular and vascular sites. Kidney Int. 1992 Jun; 41(6):1690-700.
    View in: PubMed
    Score: 0.094
  17. IFN-a confers resistance of systemic lupus erythematosus nephritis to therapy in NZB/W F1 mice. J Immunol. 2011 Aug 01; 187(3):1506-13.
    View in: PubMed
    Score: 0.088
  18. Selective blockade of BAFF for the prevention and treatment of systemic lupus erythematosus nephritis in NZM2410 mice. Arthritis Rheum. 2010 May; 62(5):1457-68.
    View in: PubMed
    Score: 0.081
  19. Interferon-alpha treatment of female (NZW x BXSB)F(1) mice mimics some but not all features associated with the Yaa mutation. Arthritis Rheum. 2009 Apr; 60(4):1096-101.
    View in: PubMed
    Score: 0.075
  20. Systemic lupus international collaborating clinics renal activity/response exercise: comparison of agreement in rating renal response. Arthritis Rheum. 2008 Jun; 58(6):1789-95.
    View in: PubMed
    Score: 0.071
  21. Systemic lupus international collaborating clinics renal activity/response exercise: development of a renal activity score and renal response index. Arthritis Rheum. 2008 Jun; 58(6):1784-8.
    View in: PubMed
    Score: 0.071
  22. Activated renal macrophages are markers of disease onset and disease remission in lupus nephritis. J Immunol. 2008 Feb 01; 180(3):1938-47.
    View in: PubMed
    Score: 0.069
  23. Polyreactive autoantibodies are nephritogenic in murine lupus nephritis. J Immunol. 1987 Nov 15; 139(10):3287-94.
    View in: PubMed
    Score: 0.068
  24. FcR-bearing myeloid cells are responsible for triggering murine lupus nephritis. J Immunol. 2006 Nov 15; 177(10):7287-95.
    View in: PubMed
    Score: 0.064
  25. Role of the H-2 haplotype in Fas-intact lupus-prone MRL mice: association with autoantibodies but not renal disease. Arthritis Rheum. 2003 Oct; 48(10):2992-5.
    View in: PubMed
    Score: 0.051
  26. Short term administration of costimulatory blockade and cyclophosphamide induces remission of systemic lupus erythematosus nephritis in NZB/W F1 mice by a mechanism downstream of renal immune complex deposition. J Immunol. 2003 Jul 01; 171(1):489-97.
    View in: PubMed
    Score: 0.050
  27. B cells are required for lupus nephritis in the polygenic, Fas-intact MRL model of systemic autoimmunity. J Immunol. 1999 Oct 01; 163(7):3592-6.
    View in: PubMed
    Score: 0.039
  28. Idiotype usage by polyclonally activated B cells in experimental autoimmunity and infection. Clin Exp Immunol. 1999 Feb; 115(2):275-80.
    View in: PubMed
    Score: 0.037
  29. Estrogen Receptor a Signaling Exacerbates Immune-Mediated Nephropathies through Alteration of Metabolic Activity. J Immunol. 2018 01 15; 200(2):512-522.
    View in: PubMed
    Score: 0.034
  30. Are DNA antibodies actually pathogenic? Lupus. 1997; 6(3):307-9.
    View in: PubMed
    Score: 0.032
  31. Cross-reactivity distinguishes serum and nephritogenic anti-DNA antibodies in human lupus from their natural counterparts in normal serum. J Autoimmun. 1990 Apr; 3(2):215-35.
    View in: PubMed
    Score: 0.020
  32. The origin of anti-nuclear antibodies in bcl-2 transgenic mice. Int Immunol. 2000 Mar; 12(3):353-64.
    View in: PubMed
    Score: 0.010
  33. Induction of autoimmunity in a transgenic model of B cell receptor peripheral tolerance: changes in coreceptors and B cell receptor-induced tyrosine-phosphoproteins. J Immunol. 1999 Nov 15; 163(10):5287-97.
    View in: PubMed
    Score: 0.010
  34. The central and multiple roles of B cells in lupus pathogenesis. Immunol Rev. 1999 Jun; 169:107-21.
    View in: PubMed
    Score: 0.009
  35. The roles of B cells in MRL/lpr murine lupus. Ann N Y Acad Sci. 1997 Apr 05; 815:75-87.
    View in: PubMed
    Score: 0.008
  36. Murine lupus in the absence of alpha beta T cells. J Immunol. 1996 May 15; 156(10):4041-9.
    View in: PubMed
    Score: 0.008
  37. The role of B cells in lpr/lpr-induced autoimmunity. J Exp Med. 1994 Oct 01; 180(4):1295-306.
    View in: PubMed
    Score: 0.007
  38. Binding of anti-DNA antibodies and inhibition of glomerulonephritis in MRL-lpr/lpr mice by heparin. Arthritis Rheum. 1990 Oct; 33(10):1554-9.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.